FDA approves Ionsys (fentanyl iontophoretic transdermal system) for Acute post-operative Pain-The Medicines Company
The FDA has approved Ionsys (fentanyl iontophoretic transdermal system), from The Medicines Company, the first needle-free, patient-controlled, pre-programmed fentanyl delivery system, for the short-term management of acute post-operative pain in adult patients requiring opioid analgesia in the hospital.
Ionsys is a novel alternative to traditional IV-PCA providing needle-free delivery of opioid analgesia with a credit-card-sized, self-adherent device employing an imperceptible electric current to deliver on-demand fentanyl. It offers patients recovering from surgery in the hospital control over their analgesic dosing by pushing a button to dispense fentanyl transdermally via an imperceptible electrical current as needed for pain.
Learning Zones
The Learning Zones are an educational resource for healthcare professionals that provide medical information on the epidemiology, pathophysiology and burden of disease, as well as diagnostic techniques and treatment regimens.
4 mins